Upstream stimulatory factor regulates E box‐dependent PAI‐1 transcription in human epidermal keratinocytes
- 15 September 2004
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 203 (1) , 156-165
- https://doi.org/10.1002/jcp.20211
Abstract
Certain growth factors (e.g., TGF-β1) initiate a “plastic” response in human keratinocytes (HaCaT cells) characterized by changes in gene expression and increased cell motility. While microarray analyses identified a number of involved genes, plasminogen activator inhibitor type 1 (PAI-1) is among the subset most highly responsive to TGF-β1. Previous antisense attenuation of PAI-1 synthesis confirmed an essential role for this protease inhibitor in cell motility (Providence et al., 2002 , J Cell Sci 115:3767–3777; Providence and Higgins, 2004 , J Cell Physiol 200:297–308). It was important, therefore, to clarify molecular mechanisms underlying PAI-1 expression control in human keratinocytes. A consensus E box motif (5′-CACGTG-3′) at nucleotides −566 to −561 in the PE2 region of the PAI-1 gene was required for TGF-β1-induced transcription of a PAI-1 promoter-driven luceriferase reporter. Truncation of the PE2 E box or mutation of the CACGTG hexanucleotide to CAATTG inhibited growth factor-stimulated promoter function confirming the importance of this site in inducible expression. A similar mutation at the PE1 E box (nucleotides −682 to −677), in contrast, did not result in reduced luciferase activity. Competing CACGTG-containing DNAs, regardless of the presence or absence of PAI-1-specific flanking sequences or lacking accessory sequences (i.e., Smad-binding sites, AAT trinucleotide spacer), inhibited complex formation between HaCaT cell nuclear factors and a 45-mer PE2 region probe. A deoxyoligonucleotide that differed from the consensus E box by a CG → AT substitution (the same base change incorporated into the PAI-1p806-lucerifase reporter by site-directed mutagenesis) but with random (i.e., non-PAI-1) flanking sequences also failed to compete with the PE2 region probe for protein binding whereas the same construct with an intact CACGTG motif was an effective competitor. The major protein/DNA interactions in the PE2 segment, therefore, are E box-dependent. USF-1, a member of the upstream stimulatory factor family, bound the PE2 construct suggesting a role for USF proteins in E box residence and PAI-1 gene expression. Chromatin immunoprecipitation, using primers designed to amplify a 300-bp PE2-associated promoter fragment and containing no other E box motifs except the target CACGTG at nucleotides −566 to −561, confirmed that this site was occupied by USF-1 or a USF-1-containing complex in both quiescent and TGF-β1-stimulated cells. Transfection of a dominant-negative USF construct effectively attenuated serum- and TGF-β1-induced PAI-1 synthesis as well as TGF-β1-stimulated Matrigel barrier invasion. Dominant-negative USF-expressing keratinocytes, moreover, specifically had a reduced capacity for Matrigel barrier invasion. USF elements, therefore, are important regulators of growth factor-initiated PAI-1 transcription (as predicted from the identification of PAI-1 as a direct USF target gene) and the associated epithelial migratory response.Keywords
This publication has 69 references indexed in Scilit:
- The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer CellsJournal of Biological Chemistry, 2003
- Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer CellsJournal of Biological Chemistry, 2002
- Promigratory Effect of Plasminogen Activator Inhibitor-1 on Invasive Breast Cancer Cell PopulationsThe American Journal of Pathology, 2002
- Linkage of M-CSF Signaling to Mitf, TFE3, and the Osteoclast Defect in Mitfmi/mi MiceMolecular Cell, 2001
- Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1Journal of Biological Chemistry, 2001
- Growth State-Dependent Binding of USF-1 to a Proximal Promoter E Box Element in the Rat Plasminogen Activator Inhibitor Type 1 GeneExperimental Cell Research, 2000
- Loss of USF transcriptional activity in breast cancer cell linesOncogene, 1999
- Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-?1Journal of Cellular Physiology, 1999
- Urokinase expression and binding activity associated with the transforming growth factor ?1-induced migratory and invasive phenotype of mouse epidermal keratinocytesJournal of Cellular Biochemistry, 1999
- Co‐expression of urokinase, urokinase receptor and PAI‐1 is necessary for optimum invasiveness of cultured lung cancer cellsInternational Journal of Cancer, 1995